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A B S T R A C T
Severe malaria is a medical emergency that requires urgent recognition and treatment, because it may rapidly prog-
ress to serious complications and death. We report a case of imported severe malaria tropica in an adult traveller, with a
parasitemia of 20%, complicated by acute renal failure. Patient was initially misdiagnosed by a physician unaware of the
importance of patients travel history, as having a viral infection. Despite the treatment delay, the patient was successfully
cured with parenteral artemether combined with peroral mefloquine and vigorous supportive measures including renal
replacement therapy.
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Introduction
Malaria is one of the most common infectious diseases
worldwide, causing 350–500 million illnesses and a mil-
lion deaths per year1. Due to increase in global travelling
incidence of imported malaria has risen, and approxi-
mately 8,000 cases of imported malaria are reported in
Europe yearly2. In a large survey of travel clinics, ma-
laria was the most frequent cause of fever without local-
izing signs or symptoms, and it was particularly common
in febrile travellers returning from Africa3.
Severe malaria is defined by major signs of organ dys-
function or a hyperparasitemia (³5% parasitemia in low-
-transmission and ³10% in high-transmission regions),
and is almost exclusively caused by Plasmodium falci-
parum4. It usually occurs in individuals without immu-
nity to malaria or in those with decreased immunity,
such as visitors from non-endemic regions to endemic re-
gions and young children (1 month to 5 years of age).
Pregnant women are also at increased risk for severe
malaria5. Travellers returning from endemic regions are
at risk of progression from uncomplicated to severe ma-
laria if the infection is not recognized and treated on
time. Severe malaria can evolve within few hours, thus
enormously increasing the mortality risk (up to 20%),
even in patients taken adequate antimalaric drugs4. Sin-
ce the disease often starts with unspecific signs, lacking
the typical fever pattern, a proper travel history and con-
sideration of malaria in all febrile patients with a history
of travel to endemic regions, as well as appropriate anti-
-malarial treatment initiation on time, are extremely im-
portant steps in successful treatment of these patients.
Case Report
We present a case of a 56-year old male with a 5-day
history of intermittent fever, chills, headache, vomitus
and diarrhoea. His family doctor evaluated his symptoms
three days before admission to our hospital and diag-
nosed him with a viral disease. The patient had returned
from a 6-months stay in Nigeria a week before disease
onset. He reported receiving recommended immuniza-
tions before his travel, but without taking any anti-ma-
larial chemoprophylaxis. The patient had no medical his-
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tory beside previous antimalaric treatment for tertian
malaria (caused by Plasmodium vivax) acquired 12 years
earlier, while working in Congo, Africa.
Initial physical examination revealed the patient with
fever up to 39 °C. He was prostrated but alert, had mild
jaundice and hepatomegaly. Routine laboratory tests
showed thrombocytopenia (19´109/L) with a normal ery-
throcyte count (4.9´1012/L), haemoglobin concentration
(145 g/L) and leukocyte count (9.6´109/L). C-reactive
protein (272 mg/L), urea (31.5 mmol/L), creatinine (478
mmol/L) as well as bilirubin (92 mmol/L), alanine amino-
transpherase (77 U/L), aspartate aminotranspherase (84
U/L) and lactate dehidrogenase (652 U/L) concentrations
were elevated. Serum sodium concentration (134 mmol/
L) was low, while potassium and glucose levels were nor-
mal. Urine analysis showed proteinuria, hemoglobinuria,
microscopic hematuria (8–10 red cells/mL) and leuko-
cyturia (10–15 white cells/mL). Chest X-ray and abdomi-
nal ultrasound were normal, except for a mild hepatome-
galy. A Giemsa-stained blood smear revealed numerous
ring forms of P. falciparum, with a hyperparasitemia of
20%. The patient was diagnosed with severe falciparum
malaria and artemether therapy was started immedi-
ately (3.2 mg/kg intra-muscular on day 1, followed by 1.6
mg/kg daily, from days 2 to 7) combined with oral me-
floquine during the first two days of treatment (750 mg
once, followed by 500 mg and 250 mg in intervals of 8
hours). Successful antimalaric treatment resulted in un-
detectable parasitemia in blood smears by the fourth day
of therapy. Despite intensive parenteral rehydration, the
patient became anuric with further rise in creatinine and
urea levels (creatinine levels were elevated up to 789
ìmol/L and urea levels up to 43.2 mmol/L, respectively), so
haemodialysis was initiated and continued over the next
3 weeks. During the course of treatment the patient de-
veloped severe anaemia (decreased erythrocyte count to
2.44´1012/L and haemoglobin level to 63 g/L, respec-
tively) which required erythrocyte transfusion. He recov-
ered gradually and was discharged after four weeks of
hospitalization when clinical and laboratory examina-
tions showed significant improvement. During two-month
follow-up, all laboratory parameters returned to normal
values.
Discussion
The vast majority of malaria cases present as non-spe-
cific febrile illnesses that are relatively easily terminated
by anti-malarial treatment6. If the disease is not recog-
nised it can progress to severe form, with numerous com-
plications and a high mortality. Acute, life-threatening
complications include severe shock, cerebral malaria,
pulmonary oedema, hepatic or renal impairment7–9. Ma-
laria – associated renal failure is a consequence of tubu-
lar renal necrosis and often requires some form of renal
replacement therapy. According to the WHO guidelines,
artemisinin derivatives are preferred drugs for severe
malaria in adults and children in regions of low trans-
mission10 due to their superior efficacy, fewer side effects
and a better safety profile as compared to intravenous
quinidine. However, the poor availability of artemisinins
outside Asia and the fact that they are not registered in
many countries, leads to logistic and legal problems, of-
ten causing a delay in antimalaric therapy. Our patient
received the only readily available parenteral artemi-
sinins, artemether for intramuscular applications, in com-
bination with peroral mefloquine, with a great success.
Mefloquine is given to prevent recrudescence and is an
adequate choice in case that no signs of cerebral malaria
are present. The patient recovered completely, without
any permanent sequelae. Despite the hyperparasitemia,
no other adjunctive treatment modalities, like blood ex-
change transfusion or erythrocyte aphaeresis, were nec-
essary.
The presented case underlines the outmost priority of
rapid recognition, proper clinical assessment and admin-
istration of full dose parenteral anti-malarial treatment
with any available effective anti-malarial drug6. In con-
clusion, it is extremely important for physicians to con-
sider malaria in all febrile patients and patients who
present with any of possible malaria-related complica-
tions, who have a history of travel in malaria-endemic re-
gions.
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AKUTNO BUBRE@NO ZATAJENJE KAO POSLJEDICA ZAKA[NJELE DIJAGNOZE
TROPSKE MALARIJE
S A @ E T A K
Te{ki oblik malarije predstavlja medicinsku hitno}u koja zahtijeva pravovremeno prepoznavanje i lije~enje. U su-
protnom slu~aju dolazi do brzog razvoja ozbiljnih komplikacija s mogu}im smrtnim ishodom. Prikazujemo slu~aj mu{-
karca s te{kim oblikom tropske malarije obilje`ene parazitemijom od 20% i akutnim bubre`nim zatajenjem. Bolesnika
je inicijalno pregledao obiteljski lije~nik koji je dijagnosticirao bla`i oblik virusne infekcije, zanemaruju}i epidemiolo{ku
anamnezu. Unato~ odgo|enom po~etku terapije, bolesnik je izlije~en bez trajnih posljedica, parenteralnom primjenom
artemetra u kombinaciji s peroralnim meflokinom, uz suportivne mjere, uklju~uju}i i hemodijalizu.
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